Table 2.
The association between baseline Tyg level and the risk of unfavorable outcome.
| The number of events (unfavorable outcome), n (%) | Crude model | Minimally adjusted model | Fully adjusted model | ||||
|---|---|---|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | ||
| All patients | 103 | 2.690 (1.832–3.950) | <0.001 | 3.445 (1.861–6.376) | <0.001 | 3.474 (1.536–7.855) | 0.002 |
| Tyg tertiles | |||||||
| Q1 (<8.376) | 13 | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | |||
| Q2 (8.376–8.804) | 22 | 1.984 (1.037–3.797) | 0.039 | 2.589 (0.675–9.924) | 0.165 | 2.125 (0.916–4.930) | 0.265 |
| Q3 (>8.804–9.268) | 28 | 4.045 (2.169–7.543) | <0.001 | 4.714 (1.396–15.924) | 0.013 | 4.529 (1.076–19.069) | 0.039 |
| Q4 (>9.268) | 40 | 6.860 (2.022–23.281) | 0.002 | 6.777 (1.455–31.557) | 0.015 | ||
Crude model: age, gender.
Minimally adjusted model: age, gender, Grabe, SEBES, IVH, GCS, WFNS, Hunt Hess score, loss of consciousness, treatment modality, hypertension, history of heart disease, hyperlipemia, body mass index, postoperative ventriculomegaly, abnormal liver function, anemia, pneumonia, and DVT.
Fully adjusted model: age, gender, Grabe, SEBES, IVH, GCS, WFNS, Hunt Hess score, loss of consciousness, treatment modality, hypertension, history of heart disease, hyperlipemia, body mass index, postoperative ventriculomegaly, abnormal liver function, anemia, pneumonia, DVT, max diameter of aneurysm, preoperative Glu, preoperative urea, preoperative eGFR, preoperative AST, preoperative ALB, preoperative CHO, preoperative CKMb, preoperative WBC, preoperative MONO, preoperative NEUT, and preoperative HGB.